China Animal Vaccine Market Analysis to 2017 in New Research Report at ReportsnReports.com
“China Animal Vaccine Industry Report, 2012-2015” and “Research on China´s Animal Vaccine Industry, 2013-2017” are new research report available at ReportsnReports.com store.
Dallas, Texas (PRWEB) June 15, 2013
In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Beginning in 2004, it has gradually included highly pathogenic avian influenza, highly pathogenic PRRS (porcine reproductive and respiratory syndrome), classical swine fever and peste des petits ruminants in the national compulsory immunization coverage following the FMD (foot-and-mouth disease), thus leading to rapid growth in animal vaccine market size.
In 2004-2012, China´s animal vaccine market (http://www.reportsnreports.com/reports/164916-china-animal-vaccine-industry-report-2011-2012.html) size grew at a CAGR as high as 26.4%, up to approximately RMB 9.1 billion in 2012 (including net import). For years to come, the market is expected to continue to maintain a growth rate of 15% or so, to RMB 15.9 billion in 2016.
Chinese animal vaccine products include swine vaccine, poultry vaccine, cattle & sheep vaccine, pet and other vaccines. As pig and poultry breeding is the core of China´s animal husbandry, swine and poultry vaccines account for more than 85% of China´s animal vaccine market. In addition, the emerging pet industry is boosting vigorous growth in demand for pet vaccine, while there are few commercial pet vaccines from Chinese animal vaccine companies, mainly dependent on imported products with stiff prices. In future, the Chinese pet vaccine market will usher in large room for promotion.
In 2006, China carried out compulsory veterinary drug GMP certification, raised the industry access threshold, which brought a substantial decline in the number of animal vaccine enterprises, accompanied by increased industry concentration. “In 2012, among domestic leading animal vaccine enterprises, China Animal Husbandry Industry Co., Ltd. made the highest animal vaccine revenue of RMB 1.17 billion, with market occupancy up to 12.9%; followed by Qingdao Yebio Bioengineering Co., Ltd (Zhejiang Shenghua Biok Biology Co., Ltd holds 38% stake), Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd., Guangdong Dahuanong Animal Health Products Co., Ltd., Inner Mongolia Jinyu Group Stock Company, etc.”
The Chinese animal vaccine market can be divided into two segments, i.e. government-procured compulsory immunization vaccines and market-oriented vaccines. Currently, there are merely five kinds of compulsory immunization vaccines, and more vaccines are market-oriented. However, in China, compulsory immunization vaccines still hold a market share of over 50%, with highly fierce competition but limited growth potential; by contrast, market-oriented vaccines will enjoy a larger space for development no matter in new product development or in the animal protection improvement.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=164916.
China Animal Vaccine Industry Report, 2012-2015 of ResearchInChina mainly covers the followings:
- Market size, market structure, competition pattern, etc. of global animal vaccine industry;
- Market size, market structure, competition pattern, import & export, etc. of China animal vaccine industry;
- Policy environment, social environment, downstream demand, etc. of China animal vaccine industry;
- Scale & structure prediction for China animal vaccine market and market segments;
- Operation, animal vaccine business, forecast & outlook, etc. of 10 animal vaccine producers in China.
Research on China´s Animal Vaccine Industry, 2013-2017 (http://www.reportsnreports.com/reports/215143-research-on-chinas-animal-vaccine-industry-2013-2017.html) – Animal vaccine sales amount in China was about CNY 7.11 billion (excluding net imports); the sales amount of swine vaccine and poultry vaccines were CNY 3.51 billion and 3.01 billion respectively, accounting for 49.4% and 42.3% of the total sales amount respectively. The market scale of China’s animal vaccine is nearly CNY 10 billion in 2012.
“Among the key animal vaccine manufacturers in China, China Animal Husbandry Industry Co., Ltd (CAHIC) obtained the highest business income in the first half of 2012–CNY 964 million, accounting for 14.3% market share. TECON, Dahuanong and Jinyu Group also had more than 5% market share respectively. The sales of these companies mainly came from the national mandatory vaccine procurement policy. The proportion of the national mandatory vaccine procurement accounted for 82.7% of CAHIC´s total income in the first half of 2012.”
In recent years, animal mandatory immunization coverage is gradually expanded in China. Restricted by the economic conditions, compulsory vaccination epidemics only cover five kinds of animal disease. While there are about 17 kinds of animal diseases; other diseases also have great hazard. With farming enterprises and farmers enhanced emphasis on the prevention and control of animal diseases, the demand of conventional vaccine at their own expense will be further improved in the future. Swine and poultry are the main species in China´s livestock breeding, newcastle disease vaccine and porcine circovirus vaccine will be the two conventional vaccines with very good market prospects.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=215143.
Explore more reports on Pharmaceutical Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/.
ReportsnReports.com is an online market research reports (http://www.reportsnreports.com/) library of 200,000+ reports and in-depth studies of 5000+ micro markets.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebchina-animal-vaccine/market-analysis-2017/prweb10834518.htm